Bhuminder Singh

Assistant Professor

Vanderbilt University Medical Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Bhuminder Singh is an Assistant Professor at Vanderbilt University Medical Center in the United States. His research focuses on understanding disparities in tumor genomic profiles, mechanisms of chemoresistance in colorectal and gastric cancers, and the development of novel EGFR inhibitors. Recent publications highlight his work on metabolic responses to cancer therapies and the importance of diversity in clinical trial leadership.

Articles (12)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (7)

Jungyoon Choi

Assistant Professor

St. Anne's University Hospital

SOUTH KOREA

View details

Benjamin Brown

Research Assistant Professor

Vanderbilt University

UNITED STATES

View details

Adam Smith

Associate Professor

Texas Tech University

UNITED STATES

View details

Christine Lovly

Associate Professor of Medicine with Tenure

Vanderbilt University Medical Center

UNITED STATES

View details

Allison Walker

Assistant Professor

Vanderbilt University

UNITED STATES

View details

Kaitlyn Ledwitch

Research Assistant Professor

Vanderbilt University

UNITED STATES

View details

Robert Coffey

Professor

Vanderbilt University Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Bhuminder Singh

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Pan-cancer analyses reveal disparities in tumor genomic profiles by race/ethnicity, age, and sex

Analysis of EGFR binding hotspots for design of new EGFR inhibitory biologics

The Roles of RAC1 and RAC1B in Colorectal Cancer and Their Potential Contribution to Cetuximab Resistance

Inhibition of autocrine HGF maturation overcomes cetuximab resistance in colorectal cancer

Sequence and structural insights of monoleucine-based sorting motifs contained within the cytoplasmic domains of basolateral proteins

Metabolic Response to Small Molecule Therapy in Colorectal Cancer Tracked with Raman Spectroscopy and Metabolomics

Monitoring Metabolic Changes in Response to Chemotherapies in Cancer with Raman Spectroscopy and Metabolomics

The room where it happens: addressing diversity, equity, and inclusion in National Clinical Trials Network clinical trial leadership

A CGA/EGFR/GATA2 positive feedback circuit confers chemoresistance in gastric cancer

Induction of apically mistrafficked epiregulin disrupts epithelial polarity via aberrant EGFR signaling

Cell surface integrin alpha 5 beta 1 clustering negatively regulates receptor tyrosine kinase signaling in colorectal cancer cells via glycogen synthase kinase 3

Probing metabolic alterations in breast cancer in response to molecular inhibitors with Raman spectroscopy and validated with mass spectrometry

Collaborators (7)

Jungyoon Choi

Benjamin Brown

Adam Smith

Christine Lovly

Allison Walker

Kaitlyn Ledwitch

Robert Coffey

Make your next move.